Search for: "Pharmaceutical Research v. FTC"
Results 21 - 40
of 83
Sorted by Relevance
|
Sort by Date
31 Mar 2017, 7:35 am
FTC is a NRTI (nucleoside reverse transcriptase inhibitor). [read post]
6 Feb 2009, 12:41 pm
—————– Violators would forfeit their 180-day exclusivity period: Section 505 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 355(j)(5)(D)(i)(V)) is amended by inserting `section 29 of the Clayton Act or’ after `that the agreement has violated’. [read post]
15 Oct 2014, 6:30 pm
In Sorrell v. [read post]
4 Feb 2007, 8:45 pm
The Voluntary Trade Blog reports that FTC Commissioner William Kovacic, in a recent interview with Dow Jones, harshly critized the Department of Justice for advising the Supreme Court not to take the FTC v. [read post]
7 Apr 2013, 7:26 pm
ChristineWhite (FTC) spoke next, commenting on FTC v Actavis and strongly emphasizing that she did not speak on behalf of the FTC. [read post]
18 Mar 2012, 5:05 pm
The Congressional Research Service has issued two reports with respect to pending legislation regarding the pharmaceutical industry. [read post]
15 Sep 2011, 4:06 am
The FTC still keeps an eye on them and keeps filing amicus briefs to make sure courts realize how damaging that practice is. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
28 Jan 2025, 4:00 am
The Supreme Court considered the issue in FTC v. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
22 Feb 2012, 10:21 am
" Festo v. [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog)… [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
15 May 2009, 6:05 pm
University of Missouri v. [read post]
16 Oct 2014, 5:30 am
It could use its compulsion powers to generate more research data from doctors and pharmaceutical companies and make it available to researchers. [read post]
2 Apr 2019, 3:46 pm
Sandoz, FTC v. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360)… [read post]
3 Apr 2011, 6:59 am
The FTC has lamented post-merger price hikes for life sustaining drugs (see FTC v. [read post]
15 Mar 2019, 9:00 am
That means that scientific researchers can now study hemp. [read post]
15 Aug 2024, 9:33 pm
Prior to the 2021 decision in Google v. [read post]
